Oncospace Inc. announces channel partner agreement with Tecnologie Avanzate
BALTIMORE, JUNE 6, 2023—Oncospace, Inc. today announced the following:
Channel Partnership Agreement with Tecnologie Avanzate
Oncospace has entered into an exclusive channel partnership agreement with Tecnologie Avanzate for the sale and distribution of the Oncospace Patient Data Conversion service in Italy.
Since its establishment, Tecnologie Avanzate has introduced innovative medical technologies to the Italian market, in the fields of nuclear medicine, medical physics, radiotherapy, and diagnostics. Oncospace is proud to work with such a forward thinking and trusted partner.
Learn more at: www.oncospace.com/why/pdc or www.tecnologieavanzate.com
ABOUT Oncospace, Inc.: Oncospace attracts and best serves, lean, high-throughput radiation oncology clinics that share a vision of disrupting current radiotherapy planning conventions. Together, we collaborate on AI-powered, data-driven, automation strategies that optimize outcomes for the patient and the practice. Our cloud-native, data analytics platform is built with industry leading security and healthcare connectivity that leverages a customer’s existing investments in clinical software applications. For more information, visit www.oncospace.com and follow us on LinkedIn:
(https://www.linkedin.com/company/oncospace-inc/about/).
Contact:
Todd Deterding; Oncospace, Inc.
(443) 773-2271
